FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway

Jiachen Liu, Shiyu Huang, Yanguang Hou, Shujie Fu, Lei Wang, Juncheng Hu, Cheng Liu, Xiuheng Liu · 2024

Read FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway by Jiachen Liu, Shiyu Huang, Yanguang Hou, Shujie Fu, Lei Wang, Juncheng Hu, Cheng Liu, Xiuheng Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11599922.txt.

Description

Jiachen Liu and co-authors show in 2024 that a hormone sensor called FXR helps drive the most common kidney cancer. The sensor is better known for roles in gut tumors, where it often holds cancer back. In clear cell kidney cancer, the team found the opposite. Lab tests showed FXR binds directly to the switch of a gene called MMP-7. That gene feeds a program that lets cells change shape and spread.

In mouse tumors, the FXR-to-MMP-7 link shaped growth as expected. The result flips the usual view of FXR and opens a fresh treatment angle for this cancer. Blocking the pathway may slow the disease, the authors suggest.

Catalog record

CREATORJiachen Liu, Shiyu Huang, Yanguang Hou, Shujie Fu, Lei Wang, Juncheng Hu, Cheng Liu, Xiuheng Liu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11599922

Browse the full library · About the Tower of Babel